PremonIQ gives PE firms a systematic diagnostic across their portfolio companies. Two entry points: surface hidden risks in companies that look healthy, or identify root causes when performance is already declining. Every quarter spent fixing the wrong problem is capital burned and exit value left on the table.
Private equity firms use sophisticated software to track financial performance across their portfolios. Revenue growth. Margins. Cash conversion. Valuation multiples.
These tools answer: "How is the company performing?"
They cannot answer: "Is the organisation capable of executing its growth plan?"
A company can hit its quarterly targets while its operations silently deteriorate. By the time revenue declines, the underlying causes have been compounding for months — sometimes years.
PremonIQ fills this gap.
The typical time to turn around declining growth in a portfolio company. Early detection is not optional — it's the difference between a correction and a crisis.
The portfolio company appears healthy. Targets are being met. But can the organisation actually deliver your 3x growth thesis?
PremonIQ runs a systematic maturity assessment across 10 functional areas, reveals hidden capability gaps, and tests whether the growth plan is achievable — or whether you're heading for a surprise in 12 months.
Growth is flat. Churn is rising. Cash is burning. The board has theories, but nobody agrees on the root cause — and the last two initiatives didn't move the needle.
PremonIQ captures symptoms, investigates competing root causes, and surfaces where your leadership team disagrees. You get a ranked diagnosis of what's actually blocking value creation — with confidence levels.
Traditional operational assessments take 6-8 weeks and a consulting engagement. PremonIQ delivers a ranked constraint diagnosis in a fraction of the time.
Input time per C-level. Split across functional leaders.
From input completion to delivered diagnostic.
PE review time. Ranked output, not raw data.
Every PremonIQ diagnostic produces a ranked constraint analysis with confidence levels — not a generic heatmap. Here's what the output looks like:
Win rate declined from 35% to 22% over 6 months. 40% of pipeline is outside core ICP. Sales cycle lengthened from 45 to 78 days.
CEO believes product-market fit is strong. CRO reports declining win rates and ICP drift. Both cannot be right.
No single growth owner. CEO/CRO misalignment on segment strategy is unresolved.
Fix ICP targeting before hiring more reps. Hiring now = 6+ months ramp time + cash burned on the wrong segment.
Identify what's actually blocking value creation. PremonIQ analyses operational signals, investigates competing root causes, and ranks the dominant constraints with confidence levels. Not a scorecard — a diagnosis.
Multiple leaders answer independently. PremonIQ surfaces where your management team disagrees — on priorities, on root causes, on what's working. The disagreements your board meetings aren't showing you.
10 functional areas. 200 diagnostic dimensions. A structured framework that turns operational complexity into clear, scoreable signals — contextualised against the company's growth stage.
Constraint patterns across your portfolio at a glance. Which companies share the same bottleneck? Where is growth thesis risk concentrated? Compare cohorts and prioritise value creation initiatives across the fund.
Upload strategy decks, org charts, financial reports. AI extracts insights and suggests maturity scores with cited reasoning. No integrations required — upload documents, get insights.
Action-oriented dashboard showing changes and exceptions — not static state. Fund filtering, alerts, and drill-down to every detail.
Most portfolio monitoring tools tell you what happened. PremonIQ tells you what's about to happen — and what to do about it.
A company can score well on maturity assessments and still have flat growth. Maturity tells you where you are. Constraint analysis tells you what's blocking you. PremonIQ does both.
When the CEO says one thing and the CRO says another, most tools average the input. PremonIQ flags the disagreement as a signal. Misalignment is often the constraint.
Quarterly re-assessment tracks whether changes are working. Monthly pulse checks catch emerging risks. Constraints shift — your diagnostic should too.
PremonIQ outputs plug directly into board decks, IC memos, LP reports, and quarterly reviews. No new workflows to learn — just better evidence behind the decisions you're already making.
Schedule a walkthrough and discover how PremonIQ can give your portfolio the forward-looking visibility it needs.